Search Results - Enric Monreal

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    Time to rethink the reported disease-modifying treatment effects on cognitive outcomes: Methods and interpretative caveats by Andrés Labiano-Fontcuberta, Enric Monreal, Julián Benito-León, Julián Benito-León, Julián Benito-León

    Published in Frontiers in Neurology (2022-09-01)
    Get full text
    Article


  2. 2

    Value contribution of blood-based neurofilament light chain as a biomarker in multiple sclerosis using multi-criteria decision analysis by Enric Monreal, Pilar Díaz Ruiz, Isabel López San Román, Alfredo Rodríguez-Antigüedad, Miguel Ángel Moya-Molina, Ana Álvarez, Elena García-Arcelay, Jorge Maurino, John Shepherd, Álvaro Pérez Cabrera, Luisa María Villar

    Published in Frontiers in Public Health (2024-04-01)
    Get full text
    Article


  3. 3

    Establishing the best combination of the kappa free light chain index and oligoclonal bands for an accurate diagnosis of multiple sclerosis by Enric Monreal, José Ignacio Fernández-Velasco, Ana García-Soidán, Susana Sainz de la Maza, Mercedes Espiño, Noelia Villarrubia, Fernando Rodríguez-Jorge, Juan Luís Chico-García, Raquel Sainz-Amo, Jaime Masjuan, Lucienne Costa-Frossard, Luisa María Villar

    Published in Frontiers in Immunology (2023-10-01)
    Get full text
    Article


  4. 4

    COVID-19 vaccines are not associated with axonal injury in patients with multiple sclerosis by Susana Sainz de la Maza, Alexander Rodero-Romero, Enric Monreal, Juan Luis Chico-García, Noelia Villarrubia, Fernando Rodríguez-Jorge, José Ignacio Fernández-Velasco, Raquel Sainz-Amo, Raquel Sainz-Amo, Lucienne Costa-Frossard, Jaime Masjuan, Luisa María Villar

    Published in Frontiers in Immunology (2024-08-01)
    Get full text
    Article


  5. 5

    Blood CD8+ Naïve T-Cells Identify MS Patients with High Probability of Optimal Cellular Response to SARS-CoV-2 Vaccine by Alexander Rodero-Romero, Susana Sainz de la Maza, José Ignacio Fernández-Velasco, Enric Monreal, Paulette Esperanza Walo-Delgado, Juan Luis Chico-García, Noelia Villarrubia, Fernando Rodríguez-Jorge, Rafael Rodríguez-Ramos, Jaime Masjuan, Lucienne Costa-Frossard, Luisa María Villar

    Published in Vaccines (2023-08-01)
    Get full text
    Article


  6. 6

    Soluble CD27 is an intrathecal biomarker of T-cell-mediated lesion activity in multiple sclerosis by Maria T. Cencioni, Roberta Magliozzi, Ilaria Palmisano, Keittisak Suwan, Antonella Mensi, Laura Fuentes-Font, Luisa M. Villar, José I. Fernández-Velasco, Noelia Villarrubia Migallón, Lucienne Costa-Frossard, Enric Monreal, Rehiana Ali, Marina Romozzi, Nicholas Mazarakis, Richard Reynolds, Richard Nicholas, Paolo A. Muraro

    Published in Journal of Neuroinflammation (2024-04-01)
    Get full text
    Article


  7. 7

    Effect of alemtuzumab over sNfL and sGFAP levels in multiple sclerosis by Raquel Sainz-Amo, Raquel Sainz-Amo, Alexander Rodero Romero, Enric Monreal, Juan Luis Chico García, José Ignacio Fernández Velasco, Noelia Villarrubia, Jose Luis Veiga González, Susana Sainz de la Maza, Fernando Rodríguez Jorge, Jaime Masjuan, Lucienne Costa-Frossard, Luisa María Villar

    Published in Frontiers in Immunology (2024-08-01)
    Get full text
    Article


  8. 8

    Short- and Long-Term Humoral and Cellular Immune Responses to SARS-CoV-2 Vaccination in Patients with Multiple Sclerosis Treated with Disease-Modifying Therapies by Susana Sainz de la Maza, Paulette Esperanza Walo-Delgado, Mario Rodríguez-Domínguez, Enric Monreal, Alexander Rodero-Romero, Juan Luis Chico-García, Roberto Pariente, Fernando Rodríguez-Jorge, Rubén Ballester-González, Noelia Villarrubia, Beatriz Romero-Hernández, Jaime Masjuan, Lucienne Costa-Frossard, Luisa María Villar

    Published in Vaccines (2023-04-01)
    Get full text
    Article


  9. 9

    Clusterin deficiency is associated with a lack of response to teriflunomide in multiple sclerosis by Sunny Malhotra, Nicolas Fissolo, Carmen Rodríguez‐Rivera, Enric Monreal, Marta Montpeyo, Elena Urcelay, Juan Carlos Triviño, María José Pérez‐García, Miguel F. Segura, Agustín Pappolla, Jordi Río, Andreu Vilaseca, José Ignacio Fernández Velasco, Andrés Miguez, Carlos Goicoechea, Marta Martinez‐Vicente, Luisa M Villar, Xavier Montalban, Manuel Comabella

    Published in Clinical and Translational Medicine (2024-04-01)
    Get full text
    Article


  10. 10

    Emerging biomarkers for improving pregnancy planning in multiple sclerosis by Juan Pablo Cuello, Ariana Meldaña Rivera, Enric Monreal, Ana Gómez Lozano, Ana Maria García Cano, Jose Manuel García Domínguez, José Ignacio Fernández Velasco, Lucienne Costa-Frossard França, Haydee Goicochea, Yolanda Higueras, Juan Antonio De León-Luis, Juan Antonio De León-Luis, Juan Antonio De León-Luis, Susana Sainz De La Maza, Noelia Villarrubia, Ignacio Arribas Gómez, Irene Ruiz Perez, Maria Luisa Martinez Ginés, Luisa María Villar

    Published in Frontiers in Neurology (2024-02-01)
    Get full text
    Article


  11. 11

    Identification of cellular factors associated with inflammation and neurodegeneration in multiple sclerosis by Alexander Rodero-Romero, José Ignacio Fernández-Velasco, Enric Monreal, Raquel Sainz-Amo, Roberto Álvarez-Lafuente, Manuel Comabella, Manuel Comabella, Lluís Ramió-Torrentà, Lluís Ramió-Torrentà, Lluís Ramió-Torrentà, José M. García-Domínguez, Noelia Villarrubia, Susana Sainz de la Maza, María Domínguez-Mozo, Ana Quiroga-Varela, Juan Luís Chico-García, Fernando Rodriguez-Jorge, José Luis Veiga-Gonzalez, Ernesto Roldán-Santiago, Mercedes Espiño, Eulalia Rodríguez-Martín, Gary Álvarez, Jaime Masjuan, Xavier Montalban, Xavier Montalban, Lucienne Costa-Frossard, Luisa María Villar

    Published in Frontiers in Immunology (2025-08-01)
    Get full text
    Article


  12. 12

    Corrigendum: Biomarkers of response to ocrelizumab in relapsing–remitting multiple sclerosis by Fernando Rodríguez-Jorge, José Ignacio Fernández-Velasco, Noelia Villarrubia, Julia Gracia-Gil, Eva Fernández, Virginia Meca-Lallana, Carolina Díaz-Pérez, Susana Sainz de la Maza, Eva María Pacheco, Ana Quiroga, Lluis Ramió-Torrentà, Sergio Martínez-Yélamos, Laura Bau, Enric Monreal, Ana López-Real, Alexander Rodero-Romero, Laura Borrega, Santiago Díaz, Pablo Eguía, Mercedes Espiño, Juan Luis Chico-García, Francisco Javier Barrero, María Luisa Martínez-Ginés, José Manuel García-Domínguez, Soraya De la Fuente, Irene Moreno, Raquel Sainz-Amo, Raquel Sainz-Amo, M. Alba Mañé-Martínez, Ana Caminero, Fernando Castellanos-Pinedo, Ana Gómez López, Andrés Labiano-Fontcuberta, Lucía Ayuso, Rossana Abreu, Miguel Ángel Hernández, José Meca-Lallana, Lorena Martín-Aguilar, Alfonso Muriel García, Jaime Masjuan, Lucienne Costa-Frossard, Luisa María Villar

    Published in Frontiers in Immunology (2024-12-01)
    Get full text
    Article


  13. 13

    Biomarkers of response to ocrelizumab in relapsing–remitting multiple sclerosis by Fernando Rodríguez-Jorge, José Ignacio Fernández-Velasco, Noelia Villarrubia, Julia Gracia-Gil, Eva Fernández, Virginia Meca-Lallana, Carolina Díaz-Pérez, Susana Sainz de la Maza, Eva María Pacheco, Ana Quiroga, Lluis Ramió-Torrentà, Sergio Martínez-Yélamos, Laura Bau, Enric Monreal, Ana López-Real, Alexander Rodero-Romero, Laura Borrega, Santiago Díaz, Pablo Eguía, Mercedes Espiño, Juan Luis Chico-García, Francisco Javier Barrero, María Luisa Martínez-Ginés, José Manuel García-Domínguez, Soraya De la Fuente, Irene Moreno, Raquel Sainz-Amo, Raquel Sainz-Amo, M. Alba Mañé-Martínez, Ana Caminero, Fernando Castellanos-Pinedo, Ana Gómez López, Andrés Labiano-Fontcuberta, Lucía Ayuso, Rossana Abreu, Miguel Ángel Hernández, José Meca-Lallana, Lorena Martín-Aguilar, Alfonso Muriel García, Jaime Masjuan, Lucienne Costa-Frossard, Luisa María Villar

    Published in Frontiers in Immunology (2024-11-01)
    Get full text
    Article


Search Tools: